1. Final phase I/II trial results for NM283, a new polymerase inhibitor for hepatitis C: antiviral efficacy and tolerance in patients with HCV-1 infection, including previous interferon failures;Afdhal;Hepatology,2004
2. Transmissible agent in non-A, non-B hepatitis;Alter;Lancet,1978
3. Efficient hepatitis C virus cell culture system: what a difference the host cell makes;Bartenschlager;Proc. Natl. Acad. Sci. U.S.A.,2005
4. Hepatitis C virus replicons: potential role for drug development;Bartenschlager;Nat. Rev. Drug Discov.,2002
5. The hepatitis C virus replicon system: from basic research to clinical application;Bartenschlager;J. Hepatol.,2005